Non-Antibody Products — page 38 of 47
Non-Antibody Products
Page 38 of 47
| Name | Description | Size | Catalog # | Supplier | |
|---|---|---|---|---|---|
| Acetoacetyl CoA synthetase (AACS) (NM_023928) Human Over-expression Lysate | Transient overexpression lysate of acetoacetyl-CoA synthetase (AA… | 100 µg | LY411433 |
 ORIGENE TECHNOLOGIES |
More Info |
| Human EGFR Protein (Isoform vIII, His & Avi Tag), Biotinylated | -Protein ligase (BirA enzyme) which is co-expressed. | 100µg | 29662-H27B-B |
 SINO BIOLOGICAL, INC. |
More Info |
| 2019-nCoV Spike Protein S1 (L452R, E484Q, D614G, P681R) | 2019-nCoV Spike Protein S1 (L452R, E484Q, D614G, P681R) | 100 ug, 50 ug, 20 ug, 10 ug | orb1742926 |
 BIORBYT LTD. |
More Info |
| Human Collagen, Type V, Alpha 1 (Col5A1) Elisa Kit | Human Collagen, Type V, Alpha 1 (Col5A1) Elisa Kit for detecting… | 96-well plate | EKC33231 |
 BIOMATIK |
More Info |
| YM-155 (chloride) | xenograft model at 3 and 10 mg / kg; inhibits SARS-CoV-2
| 10 mg |
36827-10 |
|
 CAYMAN CHEMICAL COMPANY
More Info
|
|
| YM-155 (chloride) | xenograft model at 3 and 10 mg / kg; inhibits SARS-CoV-2
| 25 mg |
36827-25 |
|
CAYMAN CHEMICAL COMPANY
More Info
|
|
| YM-155 (chloride) | xenograft model at 3 and 10 mg / kg; inhibits SARS-CoV-2
| 5 mg |
36827-5 |
|
CAYMAN CHEMICAL COMPANY
More Info
|
|
| YM-155 (chloride) | xenograft model at 3 and 10 mg / kg; inhibits SARS-CoV-2
| 50 mg |
36827-50 |
|
CAYMAN CHEMICAL COMPANY
More Info
|
|
| (±)-MMT5-14 | infected with SARS-CoV-2 (EC50 = 0.4 µM), as well… | 1 mg | 37829-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| (±)-MMT5-14 | infected with SARS-CoV-2 (EC50 = 0.4 µM), as well… | 5 mg | 37829-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| (±)-MMT5-14 | infected with SARS-CoV-2 (EC50 = 0.4 µM), as well… | 500 µg | 37829-500 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Punicalin | An ellagitannin with diverse biological activities; inhibits the SARS-… | 1 mg | 33714-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Punicalin | An ellagitannin with diverse biological activities; inhibits the SARS-… | 10 mg | 33714-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Punicalin | An ellagitannin with diverse biological activities; inhibits the SARS-… | 5 mg | 33714-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| MS023 | and 56 nM, respectively); inhibits methylation of the SARS-CoV-<… | 10 mg | 34786-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| MS023 | and 56 nM, respectively); inhibits methylation of the SARS-CoV-<… | 25 mg | 34786-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| MS023 | and 56 nM, respectively); inhibits methylation of the SARS-CoV-<… | 5 mg | 34786-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| MS023 | and 56 nM, respectively); inhibits methylation of the SARS-CoV-<… | 50 mg | 34786-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Recombinant Pseudomonas aeruginosa 3-ketoacyl-CoA thiolase (fadA) | Sequence: 1-391aa, full length protein. Purity >85% (SDS-PAGE). MW: 41,628… | 0.05 mg (E. coli), 0.05 mg (Yeast), 0.2 mg (E. coli) | MBS1029948 |
 MYBIOSOURCE INC. |
More Info |
| ROC-325 | ;M); reduces tumor growth in a 786-O mouse xenograft model at 50 mg / kg;… | 1 mg | 33566-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| ROC-325 | ;M); reduces tumor growth in a 786-O mouse xenograft model at 50 mg / kg;… | 10 mg | 33566-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| ROC-325 | ;M); reduces tumor growth in a 786-O mouse xenograft model at 50 mg / kg;… | 25 mg | 33566-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| ROC-325 | ;M); reduces tumor growth in a 786-O mouse xenograft model at 50 mg / kg;… | 5 mg | 33566-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| GW 280264X | cells at 1 and 10 µM; reduces ACE2 shedding and prevents S… | 1 mg | 31388-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| GW 280264X | cells at 1 and 10 µM; reduces ACE2 shedding and prevents S… | 10 mg | 31388-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| GW 280264X | cells at 1 and 10 µM; reduces ACE2 shedding and prevents S… | 5 mg | 31388-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-Cov-2 BQ.1 Omicron Variant Recombinant Spike Timer His Tag | n/a | 20 ul | orb1945937 |
BIORBYT LTD. |
More Info |
| GSK 199 (hydrochloride) | citrulline by PAD4 over PAD1, PAD2, and PAD3 in kinetic assays;… | 1 mg | 17489-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| GSK 199 (hydrochloride) | citrulline by PAD4 over PAD1, PAD2, and PAD3 in kinetic assays;… | 10 mg | 17489-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| GSK 199 (hydrochloride) | citrulline by PAD4 over PAD1, PAD2, and PAD3 in kinetic assays;… | 25 mg | 17489-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| GSK 199 (hydrochloride) | citrulline by PAD4 over PAD1, PAD2, and PAD3 in kinetic assays;… | 5 mg | 17489-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| ACE2(18-740)/Rb-Fc | for human coronaviruses SARS-CoV and SARS-CoV-2
| 100 µl |
P710-001 |
|
 FORTIS LIFE SCIENCES
More Info
|
|
| EG 00229 (trifluoroacetate salt) | cytotoxicity of paclitaxel or 5-fluorouracil in A549 lung cancer cells; r… | 1 mg | 33937-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| EG 00229 (trifluoroacetate salt) | cytotoxicity of paclitaxel or 5-fluorouracil in A549 lung cancer cells; r… | 10 mg | 33937-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| EG 00229 (trifluoroacetate salt) | cytotoxicity of paclitaxel or 5-fluorouracil in A549 lung cancer cells; r… | 25 mg | 33937-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| EG 00229 (trifluoroacetate salt) | cytotoxicity of paclitaxel or 5-fluorouracil in A549 lung cancer cells; r… | 5 mg | 33937-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| rac-X77 | An inhibitor of SARS-CoV-2 Mpro (IC50 = 4.1 µM), | 10 mg | 40779-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| rac-X77 | An inhibitor of SARS-CoV-2 Mpro (IC50 = 4.1 µM), | 100 mg | 40779-100 |
CAYMAN CHEMICAL COMPANY |
More Info |
| rac-X77 | An inhibitor of SARS-CoV-2 Mpro (IC50 = 4.1 µM), | 5 mg | 40779-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| rac-X77 | An inhibitor of SARS-CoV-2 Mpro (IC50 = 4.1 µM), | 50 mg | 40779-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| COVID N1P-N2P RT-qPCR Assay | The primers and probes in the SARS CoV2 N1PN2P… | 1 ea | 40679-10020 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Human Integrin alpha V beta 1 Heterodimer Protein (Flag & His Tag) | polyhistidine tag at the C-terminus, constructed the plasmid 2.… | 1mg | CT130-H2508H1 |
SINO BIOLOGICAL, INC. |
More Info |
| Human Integrin alpha V beta 5 Heterodimer Protein (Flag & His Tag) | a polyhistidine tag at the C-terminus, constructed the plasmid 2… | 1mg | CT129-H2508H |
SINO BIOLOGICAL, INC. |
More Info |
| Mca-AVLQSGFR-K(Dnp)-K-NH2 (trifluoroacetate salt) | A fluorogenic substrate for SARS-CoV Mpro; Mca is released upon c… | 1 mg | 37002-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Mca-AVLQSGFR-K(Dnp)-K-NH2 (trifluoroacetate salt) | A fluorogenic substrate for SARS-CoV Mpro; Mca is released upon c… | 10 mg | 37002-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Mca-AVLQSGFR-K(Dnp)-K-NH2 (trifluoroacetate salt) | A fluorogenic substrate for SARS-CoV Mpro; Mca is released upon c… | 5 mg | 37002-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| COVID-19 S1 Protein (G614) | Recombinant COVID-19 S1 Protein (G614). Purity >95% as determined by reduc… | 500 ug, 50 ug | orb1289532 |
BIORBYT LTD. |
More Info |
| COVID-19 S Protein RBD (A483) | Recombinant COVID-19 S Protein RBD (A483). Purity >95% as determined by re… | 500 ug, 50 ug | orb1289535 |
BIORBYT LTD. |
More Info |
| COVID-19 S Protein RBD (D354) | Recombinant COVID-19 S Protein RBD (D354). Purity >95% as determined by re… | 500 ug, 50 ug | orb1289543 |
BIORBYT LTD. |
More Info |
| COVID-19 S Protein RBD (F367) | Recombinant COVID-19 S Protein RBD (F367). Purity >95% as determined by re… | 500 ug, 50 ug | orb1289541 |
BIORBYT LTD. |
More Info |
| COVID-19 S Protein RBD (I341) | Recombinant COVID-19 S Protein RBD (I341). Purity >95% as determined by re… | 500 ug, 50 ug | orb1289545 |
BIORBYT LTD. |
More Info |
| COVID-19 S Protein RBD (I408) | Recombinant COVID-19 S Protein RBD (I408). Purity >95% as determined by re… | 500 ug, 50 ug | orb1289540 |
BIORBYT LTD. |
More Info |
| COVID-19 S Protein RBD (K439) | Recombinant COVID-19 S Protein RBD (K439). Purity >95% as determined by re… | 500 ug, 50 ug | orb1289538 |
BIORBYT LTD. |
More Info |
| COVID-19 S Protein RBD (L342) | Recombinant COVID-19 S Protein RBD (L342). Purity >95% as determined by re… | 500 ug, 50 ug | orb1289544 |
BIORBYT LTD. |
More Info |
| COVID-19 S Protein RBD (R458) | Recombinant COVID-19 S Protein RBD (R458). Purity >95% as determined by re… | 500 ug, 50 ug | orb1289537 |
BIORBYT LTD. |
More Info |
| COVID-19 S Protein RBD (S435) | Recombinant COVID-19 S Protein RBD (S435). Purity >95% as determined by re… | 500 ug, 50 ug | orb1289539 |
BIORBYT LTD. |
More Info |
| COVID-19 S Protein RBD (S476) | Recombinant COVID-19 S Protein RBD (S476). Purity >95% as determined by re… | 500 ug, 50 ug | orb1289536 |
BIORBYT LTD. |
More Info |
| COVID-19 S Protein RBD-SD1 (D354&Y364) | Recombinant COVID-19 S Protein RBD-SD1 (D354&Y364). Purity >95% as determi… | 500 ug, 50 ug | orb1289546 |
BIORBYT LTD. |
More Info |
| COVID-19 S Protein RBD-SD1 (F367) | Recombinant COVID-19 S Protein RBD-SD1 (F367). Purity >95% as determined b… | 500 ug, 50 ug | orb1289548 |
BIORBYT LTD. |
More Info |
| COVID-19 S Protein RBD-SD1 (R436) | Recombinant COVID-19 S Protein RBD-SD1 (R436). Purity >95% as determined b… | 500 ug, 50 ug | orb1289547 |
BIORBYT LTD. |
More Info |
| COVID-19 S Protein RBD (Y364) | Recombinant COVID-19 S Protein RBD (Y364). Purity >95% as determined by re… | 500 ug, 50 ug | orb1289542 |
BIORBYT LTD. |
More Info |
| COVID-19 S Protein RBD (Y501) | Recombinant COVID-19 S Protein RBD (Y501). Purity >95% as determined by re… | 500 ug, 50 ug | orb1289534 |
BIORBYT LTD. |
More Info |
| COVID-19 S-trimer Protein (G614) | Recombinant COVID-19 S-trimer Protein (G614). Purity >95% as determined by… | 500 ug, 50 ug | orb1289531 |
BIORBYT LTD. |
More Info |
| COVID-19 S-trimer Protein (G614&K439) | Recombinant COVID-19 S-trimer Protein (G614&K439). Purity >95% as determin… | 500 ug, 50 ug | orb1289530 |
BIORBYT LTD. |
More Info |
| Recombinant Human Hsp90 co-chaperone Cdc37(C-His) | and the target gene encoding V2-V378 is expres… | 50ug, 500ug | BP3066-50ug |
 BON OPUS BIOSCIENCES LLC |
More Info |
| HCoV-NL63 Nucleocapsid Protein | Nucleocapsid (N) Protein is the most abundant Protein found in coronavirus… | 100 ug, 1 mg | orb752338 |
BIORBYT LTD. |
More Info |
| Human HLA-A*11:01&B2M&KRASG12V (VVGAVGVGK) Tetramer Protein | -A*11:01&B2M&KRASG12V (VVGAVGVGK) Complex Protein is pro… | 200ug | HLV-H52H8-200ug |
 ACROBIOSYSTEMS USA |
More Info |
| Human HLA-A*11:01&B2M&KRASG12V (VVGAVGVGK) Tetramer Protein | -A*11:01&B2M&KRASG12V (VVGAVGVGK) Complex Protein is pro… | 25ug | HLV-H52H8-25ug |
ACROBIOSYSTEMS USA |
More Info |
| Human HLA-A*11:01&B2M&KRASG12V (VVVGAVGVGK) Tetramer Protein | .Biotinylated Human HLA-A*11:01&B2M&KRASG12V (VVVGAVGVGK… | 200ug | HLV-H52H9-200ug |
ACROBIOSYSTEMS USA |
More Info |
| Human HLA-A*11:01&B2M&KRASG12V (VVVGAVGVGK) Tetramer Protein | .Biotinylated Human HLA-A*11:01&B2M&KRASG12V (VVVGAVGVGK… | 25ug | HLV-H52H9-25ug |
ACROBIOSYSTEMS USA |
More Info |
| MI-09 | MI-09 is a SARS-CoV-2 Protease inhibitor (IC50 = 15.… | 1 g | orb1910403 |
BIORBYT LTD. |
More Info |
| Cynomolgus Integrin alpha V beta 3 (ITGAV&ITGB3) Heterodimer Protein, His Tag&Tag Free | (Accession # A0A2K5WCD3-1 & A0A2K5WYN9). Cynomolgus Int… | 1mg | IT3-C52W3-1mg |
ACROBIOSYSTEMS USA |
More Info |
| Cynomolgus Integrin alpha V beta 3 (ITGAV&ITGB3) Heterodimer Protein, His Tag&Tag Free | (Accession # A0A2K5WCD3-1 & A0A2K5WYN9). Cynomolgus Int… | 100ug | IT3-C52W3-100ug |
ACROBIOSYSTEMS USA |
More Info |
| Cynomolgus Integrin alpha V beta 5 (ITGAV&ITGB5) Heterodimer Protein, His Tag&Tag Free | (Accession # A0A2K5WCD3-1 & A0A2K5UEB4). Cynomolgus Int… | 1mg | IT5-C52W3-1mg |
ACROBIOSYSTEMS USA |
More Info |
| Cynomolgus Integrin alpha V beta 5 (ITGAV&ITGB5) Heterodimer Protein, His Tag&Tag Free | (Accession # A0A2K5WCD3-1 & A0A2K5UEB4). Cynomolgus Int… | 100ug | IT5-C52W3-100ug |
ACROBIOSYSTEMS USA |
More Info |
| Camostat mesylate | Purity > 98% by HPLC. MW: 494.5 Da | 10 mg, 50 mg | orb1147116 |
BIORBYT LTD. |
More Info |
| Berbamine (hydrochloride) | infected with SARS-CoV-2 (IC50 = 2.35 µM… | 1 g | 35593-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Berbamine (hydrochloride) | infected with SARS-CoV-2 (IC50 = 2.35 µM… | 250 mg | 35593-250 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Berbamine (hydrochloride) | infected with SARS-CoV-2 (IC50 = 2.35 µM… | 500 mg | 35593-500 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Human PRDX5 (Peroxiredoxin-5, mitochondrial) ELISA Kit | Human PRDX5 (Peroxiredoxin-5, mitochondrial) ELISA Kit for detecting PRDX5… | 96-well plate | EKF58788 |
BIOMATIK |
More Info |
| Human Integrin alpha V beta 1 (ITGAV&ITGB1) Heterodimer Protein, Tag Free&Tag Free | _002201.1 (ITGAV) & NP_002202.2 (ITGB1)). Human ITGAV&ITGB1 Heter… | 100ug | IT1-H5213-100ug |
ACROBIOSYSTEMS USA |
More Info |
| Human Integrin alpha V beta 1 (ITGAV&ITGB1) Heterodimer Protein, Tag Free&Tag Free | _002201.1 (ITGAV) & NP_002202.2 (ITGB1)). Human ITGAV&ITGB1 Heter… | 1mg | IT1-H5213-1mg |
ACROBIOSYSTEMS USA |
More Info |
| Mouse ECHDC1 siRNA | vials (15 nmol) or 2x three 5 nmol vials (30 nmol) of lyophilize… | 15 nmol, 30 nmol, | abx914910 |
 ABBEXA LTD |
More Info |
| PF-07321332 | An inhibitor of SARS-CoV-2 Mpro (Ki = 3.11 nM); inhibits… | 1 mg | 35257-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| PF-07321332 | An inhibitor of SARS-CoV-2 Mpro (Ki = 3.11 nM); inhibits… | 10 mg | 35257-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| PF-07321332 | An inhibitor of SARS-CoV-2 Mpro (Ki = 3.11 nM); inhibits… | 25 mg | 35257-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| PF-07321332 | An inhibitor of SARS-CoV-2 Mpro (Ki = 3.11 nM); inhibits… | 5 mg | 35257-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Recombinant Arcobacter nitrofigilis N (2)-fixation sustaining protein CowN | Sequence: 1-104aa; full length protein. Purity ≥90%. cowN. MW: 12,313 Da | 0.05 mg (E. coli), 0.2 mg (E. coli), 0.05 mg (Yeast) | MBS1080227 |
MYBIOSOURCE INC. |
More Info |
| SARS S Protein (R667A, K968P, V969P) | It's been reported that SARS-CoV-2 can infect the human… | 100 ug, 1 mg | orb750333 |
BIORBYT LTD. |
More Info |
| Human AACS siRNA | vials (15 nmol) or 2x three 5 nmol vials (30 nmol) of lyophilize… | 15 nmol, 30 nmol, | abx900046 |
ABBEXA LTD |
More Info |
| Eurycomalactone | cells with HCoV-OC43 and Vero cells with SARS-CoV-2… | 1 mg | 39016-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Eurycomalactone | cells with HCoV-OC43 and Vero cells with SARS-CoV-2… | 5 mg | 39016-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| AT-511 | , SARS-CoV-2, HCoV-229E, and HCoV-OC43… | 1 mg | 33869-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| AT-511 | , SARS-CoV-2, HCoV-229E, and HCoV-OC43… | 10 mg | 33869-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| AT-511 | , SARS-CoV-2, HCoV-229E, and HCoV-OC43… | 25 mg | 33869-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| AT-511 | , SARS-CoV-2, HCoV-229E, and HCoV-OC43… | 5 mg | 33869-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| APC-Labeled Human HLA-A*30:01&B2M&KRASG12V (VVGAVGVGK) Tetramer Protein | -labeled streptavidin.Biotinylated Human HLA-A*30:01&B2M&KRASG12<… | 200ug | HLV-HA2H7-200ug |
ACROBIOSYSTEMS USA |
More Info |
| APC-Labeled Human HLA-A*30:01&B2M&KRASG12V (VVGAVGVGK) Tetramer Protein | -labeled streptavidin.Biotinylated Human HLA-A*30:01&B2M&KRASG12<… | 25ug | HLV-HA2H7-25ug |
ACROBIOSYSTEMS USA |
More Info |
| Mouse ACOT7 siRNA | vials (15 nmol) or 2x three 5 nmol vials (30 nmol) of lyophilize… | 15 nmol, 30 nmol, | abx906543 |
ABBEXA LTD |
More Info |
| PE-Labeled Human HLA-A*02:01&B2M&KRASG12V (KLVVVGAVGV) Tetramer Protein | produced by co-expression of HLA and B2M loaded with KR… | 25ug | HLV-HP2H6-25ug |
ACROBIOSYSTEMS USA |
More Info |